Monday, June 15, 2009
Genetic Immunity, InPlay Completes Patient Enrollment In Phase II Trial Of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
Genetic Immunity, InPlay Completes Patient Enrollment In Phase II Trial Of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
Shared via
AddThis
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment